Adaptimmune Therapeutics plc (ADAP) NASDAQ
0.05
-0.0015(-3.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 135.91M |
| Enterprise Value | 118.98M |
| P/E Ratio | -0.04 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.26 |
| Price/Book Ratio | -0.09 |
| Enterprise/Revenue | 1.2 |
| Enterprise/EBITDA | -0.21 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | -6.29 |
| Operating Margin | -6.18 |
Management Effectiveness
| Return On Assets | -1.16 |
| Return On Equity | 4.73 |
Income Statement
| Revenue | 178.03M |
| Revenue/Share | 0.09 |
| Gross Profit | 177.96M |
| EBITDA | -52.67M |
| Net Income | -70.81M |
| Diluted EPS | -0.28 |
Balance Sheet
| Total Cash | 26.06M |
| Total Cash/Share | 0.1 |
| Total Debt | 48.68M |
| Total Debt/Equity | -0.69 |
| Current Ratio | 1.52 |
| Book Value Per Share | -0.27 |
Price History
| 52-Week Change | -91.75 |
| 52-Week High | 0.86 |
| 52-Week Low | 0.02 |
| Moving Average 50 Days | 0.1 |
| Moving Average 200 Days | 0.26 |
Statistics
| Average Volume | 110.64M |
| Shares Outstanding | 1.55B |
| % Held by Institutions | 0.62 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
